Sinil Pharmaceutical Co., Ltd.

Research Sinil Pharmaceutical Co., Ltd. (012790.KQ) on Bullrun: market cap KRW 74.56B, dividend yield 3.0%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is KRW 74.56B; dividend yield is 3.0%.

Peer valuation comparison

Latest dividend yield is 2.95% versus a Healthcare sector median of 1.81% (63.0% above).

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-16KRW 74.56Bn/a3.0%190

Dividend history

Latest trailing dividend snapshot: annual dividend/share 190 KRW, yield 3.0%.

About Sinil Pharmaceutical Co., Ltd.

Sinil Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical products in South Korea and internationally. It offers pharmaceutical products for various indications, such as pain reliever, anti-inflammatory, hyperlipidemia, skin disease, and folic acid deficiency; and general/specialty drugs, veterinary drugs, and OEM products for various diseases. The company also provides cosmetics, including skin care products, etc.; health functional products comprising vitamin supplements;

Related stock research

South Korea stocks South Korea Healthcare stocks A-Z stock index

Other Healthcare stocks

Ilyang Pharmaceutical Co.,Ltd (007570.KS) CMG Pharmaceutical Co., Ltd. (058820.KQ) HLB Co., Ltd. (028300) Celltrion, Inc. (068270) ALTEOGEN Inc. (196170) Samsung Biologics Co.,Ltd. (207940) IVIM Technology, Inc (460470.KQ) Lee's Pharmaceutical Holdings Limited (0950.HK) Cannovum Cannabis AG (27N0.DE) Takeda Pharmaceutical Company Limited (4502) AB SCIENCE (AB.PA) AFT Pharmaceuticals Limited (AFP.AX)

Frequently asked questions

What is Sinil Pharmaceutical Co., Ltd.'s market cap?

Sinil Pharmaceutical Co., Ltd.'s market capitalization is KRW 74.56B.

Does Sinil Pharmaceutical Co., Ltd. pay a dividend?

Sinil Pharmaceutical Co., Ltd. has a dividend yield of 3.0%.

What does Sinil Pharmaceutical Co., Ltd. do?

Sinil Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical products in South Korea and internationally. It offers pharmaceutical products for various indications, such as pain reliever, anti-inflammatory, hyperlipidemia, skin disease, and folic acid deficiency; and general/specialty drugs, veterinary drugs, and OEM products for various diseases. The company also provides cosmetics, including skin care products, etc.; health functional products comprising vitamin supplements; and quasi-drugs for yellow dust, bacteria blocking, etc.